Large global contract research organisation, SFBC International,
has changed its name to PharmaNet Development Group in a bid to
make a fresh start and turnaround the troubled business after a
long period of bad press, legal difficulties...
Contract research organisations (CROs) are slashing clinical trial
times by an average of 30 per cent and the outsourcing trend is
showing no signs of slowing, as the pharma industry continues to
face rising pressure to reduce time-to-market...
Global drug development spending will top $105bn (€81.5bn) by 2010
and 40 per cent of this business is expected to be dished out in
outsourcing contracts - with contract research organisations (CROs)
Pharma firms may soon have the chance to use US prisoners in
clinical drug trials after a new report by a panel of medical
advisers at the Institute of Medicine recommended government laws
against the practice be loosened.
The use of eClinical software in clinical trials is gaining in
popularity with pharmaceutical, biotechnology and contract research
organizations (CROs), as seen by the recent financial results of
two major industry providers.